Volume 8, Issue 3 (12-2018)                   JABS 2018, 8(3): 841-853 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

A review on the most valuable biomarkers in epilepsy. JABS 2018; 8 (3) :841-853
URL: http://jabs.fums.ac.ir/article-1-1510-en.html
Abstract:   (5256 Views)
Background & Objective: Epilepsy is a common neurological disorder with the prevalence of 50 million in the world. Despite of many researches and introducing of different anti-epileptic drugs, 30% of patients suffer from refractory seizures. Biomarkers are the measurable indicators to detect the physiological and pathological condition. Biomarkers in epilepsy can be utilized for prediction, diagnosis, severity and effectiveness of drugs.
Conclusion: The efficacy of biomarkers in the prognosis and evaluation of drugs effectiveness is notable. Owing to the diversity of clinical symptoms of epilepsy, various biomarkers have been presented. Among wide-ranging biomarkers, some structural biomarkers such as imaging and electrophysiology including electroencephalogram are the most usable biomarkers. These evidences suggest more investigations to introduce biomarkers that are more practical.
Keywords: Epilepsy, Biomarkers, brain
Full-Text [PDF 1203 kb]   (4281 Downloads)    
Type of Study: Review | Subject: Neurosciece
Received: 2017/11/2 | Accepted: 2018/07/6 | Published: 2018/12/22

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)